103 related articles for article (PubMed ID: 31587870)
41. Recombinant expression and purification of AF1q and its interaction with T-cell Factor 7.
Khan N; Park J; Dean WL; Gray RD; Tse W; Lee D; Sabo TM
Protein Expr Purif; 2020 Jan; 165():105499. PubMed ID: 31541685
[TBL] [Abstract][Full Text] [Related]
42. Retinoic acid induces persistent, RARalpha-mediated anti-proliferative responses in Epstein-Barr virus-immortalized b lymphoblasts carrying an activated C-MYC oncogene but not in Burkitt's lymphoma cell lines.
Cariati R; Zancai P; Quaia M; Cutrona G; Giannini F; Rizzo S; Boiocchi M; Dolcetti R
Int J Cancer; 2000 May; 86(3):375-84. PubMed ID: 10760826
[TBL] [Abstract][Full Text] [Related]
43. Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells.
Walker A; Taylor ST; Hickman JA; Dive C
Cancer Res; 1997 May; 57(10):1939-45. PubMed ID: 9157989
[TBL] [Abstract][Full Text] [Related]
44. Midostaurin potentiates rituximab antitumor activity in Burkitt's lymphoma by inducing apoptosis.
Ge X; Chen J; Li L; Ding P; Wang Q; Zhang W; Li L; Lv X; Zhou D; Jiang Z; Zeng H; Xu Y; Hou Y; Hu W
Cell Death Dis; 2018 Dec; 10(1):8. PubMed ID: 30584254
[TBL] [Abstract][Full Text] [Related]
45. Spontaneous remission in Burkitt's lymphoma.
Ziegler JL
Natl Cancer Inst Monogr; 1976 Nov; 44():61-5. PubMed ID: 799761
[TBL] [Abstract][Full Text] [Related]
46. Synthesis and antiproliferative action of a novel series of maprotiline analogues.
McNamara YM; Bright SA; Byrne AJ; Cloonan SM; McCabe T; Williams DC; Meegan MJ
Eur J Med Chem; 2014 Jan; 71():333-53. PubMed ID: 24333581
[TBL] [Abstract][Full Text] [Related]
47. Bax is frequently compromised in Burkitt's lymphomas with irreversible resistance to Fas-induced apoptosis.
Gutiérrez MI; Cherney B; Hussain A; Mostowski H; Tosato G; Magrath I; Bhatia K
Cancer Res; 1999 Feb; 59(3):696-703. PubMed ID: 9973220
[TBL] [Abstract][Full Text] [Related]
48. Regulation of cell survival in Burkitt lymphoma: implications from studies of apoptosis following cold-shock treatment.
Gregory CD; Milner AE
Int J Cancer; 1994 May; 57(3):419-26. PubMed ID: 8169005
[TBL] [Abstract][Full Text] [Related]
49. High expression of bcl-2 is the rule in acute lymphoblastic leukemia, except in Burkitt subtype at presentation, and is not correlated with the prognosis.
Gala JL; Vermylen C; Cornu G; Ferrant A; Michaux JL; Philippe M; Martiat P
Ann Hematol; 1994 Jul; 69(1):17-24. PubMed ID: 8061103
[TBL] [Abstract][Full Text] [Related]
50. Identification of ADGRE5 as discriminating MYC target between Burkitt lymphoma and diffuse large B-cell lymphoma.
Kleo K; Dimitrova L; Oker E; Tomaszewski N; Berg E; Taruttis F; Engelmann JC; Schwarzfischer P; Reinders J; Spang R; Gronwald W; Oefner PJ; Hummel M
BMC Cancer; 2019 Apr; 19(1):322. PubMed ID: 30953469
[TBL] [Abstract][Full Text] [Related]
51. Local growth of a Burkitt's lymphoma versus disseminated invasive growth of the autologous EBV-immortalized lymphoblastoid cells and their somatic cell hybrids in SCID mice.
Walter J; Möller P; Moldenhauer G; Schirrmacher V; Pawlita M; Wolf J
Int J Cancer; 1992 Jan; 50(2):265-73. PubMed ID: 1309726
[TBL] [Abstract][Full Text] [Related]
52. Characterization and comparison of two newly established Epstein-Barr virus (EBV)-negative and EBV-positive Burkitt's lymphoma cell lines. EBV-negative cell line with a low level of expression of ICAM-1 molecule and EBV-positive cell line with a high level of expression of ICAM-1 molecule.
Abe M; Tasaki K; Tominaga K; Fukuhara S; Imai S; Osato T; Wakasa H
Cancer; 1992 Feb; 69(3):763-71. PubMed ID: 1309680
[TBL] [Abstract][Full Text] [Related]
53. Efficacy of the GMALL-B-ALL/NHL2002 protocol in Burkitt leukemia/lymphoma and aggressive non-Hodgkin-lymphomas with or without CNS involvement.
Sakarou M; Eisele L; Dührsen U; Hüttmann A
Eur J Haematol; 2019 Mar; 102(3):241-250. PubMed ID: 30471148
[TBL] [Abstract][Full Text] [Related]
54. Shikonin exerts antitumor activity in Burkitt's lymphoma by inhibiting C-MYC and PI3K/AKT/mTOR pathway and acts synergistically with doxorubicin.
Ni F; Huang X; Chen Z; Qian W; Tong X
Sci Rep; 2018 Feb; 8(1):3317. PubMed ID: 29463831
[TBL] [Abstract][Full Text] [Related]
55. Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cells.
Capoulade C; Bressac-de Paillerets B; Lefrère I; Ronsin M; Feunteun J; Tursz T; Wiels J
Oncogene; 1998 Mar; 16(12):1603-10. PubMed ID: 9569028
[TBL] [Abstract][Full Text] [Related]
56. Inhibiting Heat Shock Proteins Can Potentiate the Cytotoxic Effect of Cannabidiol in Human Glioma Cells.
Scott KA; Dennis JL; Dalgleish AG; Liu WM
Anticancer Res; 2015 Nov; 35(11):5827-37. PubMed ID: 26504004
[TBL] [Abstract][Full Text] [Related]
57. Treatment of Burkitt's lymphoma: the African experience.
Olweny CL; Nkrumah FK
IARC Sci Publ; 1985; (60):375-82. PubMed ID: 4065949
[TBL] [Abstract][Full Text] [Related]
58. Flavopiridol induces apoptosis and caspase-3 activation of a newly characterized Burkitt's lymphoma cell line containing mutant p53 genes.
Rapoport AP; Simons-Evelyn M; Chen T; Sidell R; Luhowskyj S; Rosell K; Obrig T; Hicks D; Hinkle PM; Nahm M; Insel RA; Abboud CN
Blood Cells Mol Dis; 2001; 27(3):610-24. PubMed ID: 11482875
[TBL] [Abstract][Full Text] [Related]
59. Burkitt lymphoma is immunophenotypically different from Burkitt-like lymphoma in young persons.
Hutchison RE; Finch C; Kepner J; Fuller C; Bowman P; Link M; Schwenn M; Laver J; Desai S; Barrett D; Murphy SB
Ann Oncol; 2000; 11 Suppl 1():35-8. PubMed ID: 10707776
[TBL] [Abstract][Full Text] [Related]
60. Retinoic acid induces changes in c-fgr proto-oncogene mRNA levels in Burkitt's lymphoma cells.
Faulkner L; Katz DR; Brickell PM
Immunobiology; 1993 Aug; 188(4-5):460-8. PubMed ID: 8244449
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
